Tumor Biology

, Volume 36, Issue 4, pp 3043–3049 | Cite as

Correlation between squamous cell carcinoma of the lung and human papillomavirus infection and the relationship to expression of p53 and p16

  • Xiaohong Fan
  • Keke Yu
  • Jie Wu
  • Jinchen Shao
  • Lei Zhu
  • Jie Zhang
Research Article

Abstract

The number of non-small-cell lung cancer (NSCLC) patients reported as infected with human papillomavirus (HPV) varies among countries and by race and geographical location. Furthermore, the relationship between HPV and the expressions of p53 and p16 remains unclear. A large cohort of NSCLC patients from Shanghai was studied. Paraffin sections from 128 cases of lung adenocarcinoma (ADC) and 134 cases of squamous cell carcinoma (SQC) were collected from the Shanghai Chest Hospital. Samples were analyzed by polymerase chain reaction (PCR) and reverse dot blot for detection of HPV DNA and by immunohistochemistry for detection of p53 and p16 expressions. The rate of HPV infection in SQC cases was significantly higher than in ADC cases (12.69 versus 3.91 %). Females with SQC had a significantly higher rate of HPV infection compared to males with SQC (18.75 versus 7.14 %, p = 0.044). HPV infection was correlated with gender and age in SQC but not with the degree of tumor differentiation, TNM stage, or smoking. Koilocytosis was significantly correlated to the tumor differentiation grade, regardless of age and TNM stage. The expressions of p53 and p16 were correlated with HPV infection and the tumor histological type but not with the degree of tumor differentiation, TNM stage, smoking, gender, or age. p53-positive expression was significantly higher in HPV-infected SQC cases than in those not infected with HPV. There was no statistically significant difference in the expression of p16 between the two groups. Data showed that HPV infection may be an important virulence factor in SQC, particularly in female patients. HPV infection appears to be involved in cancer progression in SQC by promoting the expression of p53; however, p16 cannot be used as a surrogate marker for HPV infection in SQC.

Keywords

Squamous cell carcinoma (SQC) Human papillomavirus (HPV) p53 p16 

Notes

Acknowledgments

This work was supported by the Shanghai R&D public service platform project “common malignant tumor biobank (Network) construction” (2012).

Conflicts of interest

None

References

  1. 1.
    Fan Y, Yuan JM, Wang R, Gao YT, Yu MC. Alcohol, tobacco, and diet in relation to esophageal cancer: the Shanghai Cohort Study. Nutr Cancer. 2008;60:354–63.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Zhang YW, Jin B, Shao MH, Dong Y, Lou YQ, Huang AM, et al. Monitoring of carcinoembryonic antigen levels is predictive of EGFR mutations and efficacy of EGFR-TKI in patients with lung adenocarcinoma. Tumour Biol. 2014;35(5):4921–8.CrossRefPubMedGoogle Scholar
  3. 3.
    Zhai K, Ding J, Shi H. HPV and lung cancer risk: a meta-analysis. J Clin Virol. 2014;09(014).Google Scholar
  4. 4.
    Fei Y, Yang J, Hsieh WC, Wu JY, Wu TC, Goan YG, et al. Different human papillomavirus 16/18 infection in Chinese non-small cell lung cancer patients living in Wuhan. China Jpn J Clin Oncol. 2006;36(5):274–9.CrossRefPubMedGoogle Scholar
  5. 5.
    Yanagawa N, Wang A, Kohler D, Santos GC, Sykes J, Xu J, et al. Human papilloma virus genome is rare in North American non-small cell lung carcinoma patients. Lung Cancer. 2013;79:215–20.CrossRefPubMedGoogle Scholar
  6. 6.
    Doxtader EE, Katzenstein AL. The relationship between p16 expression and high-risk human papillomavirus infection in squamous cell carcinoma from sites other than uterine cervix: a study of 137 cases. Hum Pathol. 2012;43:327–32.CrossRefPubMedGoogle Scholar
  7. 7.
    Wu JB, Li XJ, Zhu W, Liu XP. Detection and pathological value of papillomavirus DNA and p16INK4A and p53 protein expression in cervical intraepithelial neoplasia. Oncol Lett. 2014;7:738–44.PubMedPubMedCentralGoogle Scholar
  8. 8.
    Shamanin V, Delius H, Villiers EM. Development of a broad spectrum PCR assay for papillomaviruses and its application in screening lung cancer biopsies. J Gen Virol. 1994;75:1149–56.CrossRefPubMedGoogle Scholar
  9. 9.
    Teng HH, Li XJ, Liu XP, Wu J, Zhang J. The absence of human papillomavirus in esophageal squamous cell carcinoma in East China. Int J Clin Exp Pathol. 2014;7(7):4184–93.PubMedPubMedCentralGoogle Scholar
  10. 10.
    Sarchianaki E, Derdas SP, Ntaoukakis M, Vakonaki E, Lagoudaki ED, Lasithiotaki I, et al. Detection and genotype analysis of human papillomavirus in non-small cell lung cancer patients. Tumour Biol. 2014;35(4):3203–9.CrossRefPubMedGoogle Scholar
  11. 11.
    Welt A, Hummel M, Niedobitek G, Stein H. Human papillomavirus infection is not associated with bronchial carcinoma: evaluation by in situ hybridization and the polymerase reaction. J Pathol. 1997;181:276–80.CrossRefPubMedGoogle Scholar
  12. 12.
    Klein F, Waleed FM, Amin K, Petersen I. Incidence of human papillomavirus in lung cancer. Lung Cancer. 2009;65:13–8.CrossRefPubMedGoogle Scholar
  13. 13.
    Aguayo F, Castillo A, Koriyama C, Higashi M, Itoh T, Capetillo M, et al. Huamn papillomavirus-16 is integrated in lung carcinomas: a study in Chile. Br J Cancer. 2007;97(1):85–91.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Chen YW, Chiou HL, Chen JT, Chou MC, Lin TS, Lai WW, et al. Gender difference in human papillomavirus infection for non-small cell lung cancer in Taiwan. Lung Cancer. 2004;46:165–70.CrossRefPubMedGoogle Scholar
  15. 15.
    Wang J, Chang YW, Wu DW, Chen JT, Chen CY, Chou MC, et al. Frequent fhit gene los of heterozygosity in human papillomavirus-infected nonsmoking female lung cancer in Taiwan. Cancer Lett. 2006;235:18–25.CrossRefPubMedGoogle Scholar
  16. 16.
    Fei M, Li J, Du J, You J, Zhang S, He W, et al. Distribution human papillomavirus 16 and 18 among high-risk women to cervical cancer. Zhonghua Liu Xing Bing Xue Za Zhi. 2014;35(5):514–8.PubMedGoogle Scholar
  17. 17.
    Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55:244–65.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci. 2006;110:525–41.CrossRefPubMedGoogle Scholar
  19. 19.
    Hennig EM, Suo Z, Karlsen F, Holm R, Thoresen S, Nesland JM. HPV positive bronchopulmonary carcinomas in women with previous high-grade cervical intraepithelial neoplasis (CINIII). Acta Oncol. 1999;38:639–47.CrossRefPubMedGoogle Scholar
  20. 20.
    Katiyar S, Hedau S, Jain N, Kar P, Khuroo MS, Mohanta J, et al. P53 gene mutation and human papillomavirus (HPV) infection in esophaged carcinoma from three different endemic geographic regions of India. Cancer Lett. 2005;218:69–79.CrossRefPubMedGoogle Scholar
  21. 21.
    Hsu NY, Cheng YW, Chan IP, Ho HC, Chen CY, Hsu CP, et al. Association between expression of human papillomavirus 16/18 E6 oncoprotein and survival in patients with stage I non-small cell lung cancer. Oncol Rep. 2009;21(1):81–7.PubMedGoogle Scholar
  22. 22.
    Reimers N, Kasper HU, Weissenborn SU, Stutzer H, Preuss SF, Hoffmann TK, et al. Combined analysis of HPV-DNA, p16 and EGFR expression to precict prognosis in oropharyngeal cancer. Int J Cancer. 2007;120:1731–8.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2014

Authors and Affiliations

  • Xiaohong Fan
    • 1
    • 2
  • Keke Yu
    • 3
  • Jie Wu
    • 1
  • Jinchen Shao
    • 1
  • Lei Zhu
    • 1
  • Jie Zhang
    • 1
  1. 1.Department of Pathology, Shanghai Chest HospitalShanghai JiaoTong UniverstiyShanghaiChina
  2. 2.Department of Pulmonary Medcine, Shanghai Chest HospitalShanghai JiaoTong UniversityShanghaiChina
  3. 3.Department of Biaobank, Shanghai Chest HospitalShanghai JiaoTong UniversityShanghaiChina

Personalised recommendations